川芎嗪治疗良性阵发性位置性眩晕的疗效观察  

Clinical Effect of Ligustrazine in Patients with Benign Paroxysmal Positional Vertigo

作　　者：赵沛英[1] 李志光[1] 曹武臣[1] 

机构地区：[1]北京医科大学第一医院耳鼻咽喉科,北京100034

出　　处：《中西医结合杂志》1991年第12期719-720,共2页

摘　　要：本文介绍川芎嗪治疗良性阵发性位置性眩晕,与西药疗法比较,前者治愈时间(平均37天)明显短于后者(平均72天),P<0.05。良性阵发性位置性眩晕的病因是由于内耳前前庭动脉栓塞,致使前庭神经上终末支和椭圆囊、外半规管及上半规管变性。川芎嗪有抗血小板聚集、扩张微血管、增加血流速度等作用,因而达到较好的治疗效果。The therapeutic effect of Ligustrazine was studied in patients with benign paroxysmal positional vertigo (BPPV).11 cases were given Ligustrazine 100 mg daily (iv.or im.),another 11 cases were given Valium and Diphenidol as the control group. The results were as follows:In Ligustrazine group,the average curative time was 37 days.In the Control group,the average curative time was 72 days.This result suggests that Ligustrazine is a useful drug in the treatment of BPPV.It is believed that the cause of BPPV is due to the occlusion of the anterior vestibular arterY.Ligustrazine has the effect of improving microcirculation of the cochlea.

关 键 词：川芎嗪 良性阵发性位置性眩晕 治疗 

分 类 号：R255.305[医药卫生—中医内科学]